Loading…
Reported covered position: Leg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
Drug safety, prescription drug abuse, value of prescription drugs; HR 946/S 1862 Orphan Cures Act; Health care issues H.R. 1 (Public Law No: 119-21)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GILEAD SCIENCES, INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
IRA, pharmaceuticals access and affordability, drug pricing in federal programs, HCV screening, drug pricing and access, HIV, oncology, PAHPA reauthorization
Source: Senate LDA
| HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) |
| 12 |
| 2023–2025 |
| IDORSIA PHARMACEUTICALS US INC | 12 | 2023–2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | 12 | 2023–2025 |
| ABBOTT (FORMERLY KNOWN AS ALERE INC.) | 11 | 2023–2025 |
| ABBVIE, INC. | 11 | 2023–2025 |
| ACCENTURE FEDERAL SERVICES | 11 | 2023–2025 |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) | 11 | 2023–2025 |
| AMERICAN OSTEOPATHIC ASSOCIATION | 11 | 2023–2025 |
| AMGEN, INC. | 11 | 2023–2025 |
| AMYLYX PHARMACEUTICALS | 11 | 2023–2025 |
| BD (BECTON, DICKINSON AND COMPANY) | 11 | 2023–2025 |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 11 | 2023–2025 |
| BOEHRINGER INGELHEIM | 11 | 2023–2025 |
| CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) | 11 | 2023–2025 |
| ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) | 11 | 2023–2025 |
| ELI LILLY AND COMPANY | 11 | 2023–2025 |
| FLAGSHIP PIONEERING | 11 | 2023–2025 |
| FOUNDATION MEDICINE | 11 | 2023–2025 |
| GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) | 11 | 2023–2025 |
| GILEAD SCIENCES, INC. | 11 | 2023–2025 |
| JAZZ PHARMACEUTICALS INC. | 11 | 2023–2025 |
| MERCK | 11 | 2023–2025 |
| NOVARTIS | 11 | 2023–2025 |
| NOVO NORDISK, INC. | 11 | 2023–2025 |
| PHRMA | 11 | 2023–2025 |
| QUEST DIAGNOSTICS | 11 | 2023–2025 |
| SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) | 11 | 2023–2025 |
| SAREPTA THERAPEUTICS | 11 | 2023–2025 |
| SAS | 11 | 2023–2025 |
| THE AMPUTEE COALITION | 11 | 2023–2025 |
| VALNEVA USA, INC | 11 | 2023–2025 |
| BRISTOL MYERS SQUIBB | 10 | 2023–2025 |
| EXCELLUS HEALTH PLAN INC. | 10 | 2023–2025 |
| AMAZON.COM SERVICES LLC | 9 | 2024–2025 |
| GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS) | 9 | 2023–2025 |
| ADVAMED | 8 | 2024–2025 |
| AIS HEALTHCARE | 8 | 2023–2024 |
| AMNEAL PHARMACEUTICALS, INC. | 8 | 2024–2025 |
| CRINETICS PHARMACEUTICALS | 8 | 2024–2025 |
| LINCARE | 8 | 2023–2024 |
| LONGEVITY HEALTH PLAN | 8 | 2023–2024 |
| NOVOCURE INC. | 8 | 2023–2024 |
| THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) | 8 | 2023–2024 |
| TRIPLE-S MANAGEMENT CORPORATION | 8 | 2023–2024 |
| ASTELLAS PHARMA US, INC. | 7 | 2024–2025 |
| AMERICAN INVESTMENT COUNCIL | 6 | 2023–2025 |
| HANSA BIOPHARMA | 6 | 2024–2025 |
| MEDICALLY HOME | 6 | 2023–2024 |
| OPTION CARE HEALTH | 6 | 2024–2025 |
| EVERGREEN NEPHROLOGY | 5 | 2024 |
| HEALTH GORILLA | 5 | 2023 |
| OCTAVIANT FINANCIAL INC. | 5 | 2023–2024 |
| 10X GENOMICS | 4 | 2023 |
| ADULT VACCINE ACCESS COALITION | 4 | 2025 |
| ADVOCATES FOR COMMUNITY HEALTH | 4 | 2023 |
| BLUEPRINT BIOSECURITY ACTION | 4 | 2025 |
| HEALTHCARE LEADERSHIP COUNCIL | 4 | 2023 |
| Hims & Hers Health, Inc. | 4 | 2023–2024 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (MITA) | 4 | 2023 |
| NATIONAL SEATING & MOBILITY | 4 | 2024 |
| NEUROCRINE BIOSCIENCES, INC | 4 | 2023 |
| ONE MEDICAL | 4 | 2023 |
| UNITED NETWORK FOR ORGAN SHARING | 4 | 2025 |
Drug safety, prescription drug abuse, value of prescription drugs; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; S 891 Bipartisan Healthcare Act; HR 1968 Full Year Continuing Appropriations and Extensions Act of 2025, PL 119-4.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce
Special Diabetes Program for Indians Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce
Drug safety, prescription drug abuse, value of prescription drugs; HR 946/S 1862 Orphan Cures Act; Health care issues H.R. 1 (Public Law No: 119-21)
Drug safety, prescription drug abuse, value of prescription drugs; HR 946/S 1862 Orphan Cures Act; Health care issues H.R. 1 (Public Law No: 119-21)
Special Diabetes Program Reauthorization Act of 2025
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026
Bipartisan Health Care Act
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
Drug safety, prescription drug abuse, value of prescription drugs; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; S 891 Bipartisan Healthcare Act; HR 1968 Full Year Continuing Appropriations and Extensions Act of 2025, PL 119-4.
American Relief Act, 2025
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
American Relief Act, 2025
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 8467 - Farm, Food, and National Security Act of 2024 H.R. 10545 - American Relief Act of 2025 Drug safety, prescription drug abuse, value of prescription drugs
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act (AKAC) S. 3234, Chronic Disease Flexible Coverage Act
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Issues pertaining to NIH appropriations for FY25
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Further Consolidated Appropriations Act, 2024
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4336, the Consolidated Appropriations Act, 2024 (P.L. 118-42) H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) Drug safety, prescription drug abuse, value of prescription drugs, expiring healthcare extenders
To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information.
Client: AMERICAN INVESTMENT COUNCIL · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
Charitable Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
SCREENS for Cancer Act of 2024
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3916/S.1840 - SCREENS for Cancer Act of 2023 IRA implementation, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
SCREENS for Cancer Act of 2024
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3916/S.1840 - SCREENS for Cancer Act of 2023 IRA implementation, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preserving Patient Access to Home Infusion Act
Client: OPTION CARE HEALTH · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4104/S.1976 - Preserving Patient Access to Home Infusion Act Medicare coverage and payment for home infusion services
Preserving Patient Access to Home Infusion Act
Client: OPTION CARE HEALTH · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4104/S.1976 - Preserving Patient Access to Home Infusion Act Medicare coverage and payment for home infusion services
Summer Meals REACH Act of 2023
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4336, the Consolidated Appropriations Act, 2024 (P.L. 118-42) H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) Drug safety, prescription drug abuse, value of prescription drugs, expiring healthcare extenders
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Issues pertaining to NIH appropriations for FY25
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Small Business Tax Fairness and Compliance Simplification Act
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.45 - Small Business Tax Fairness and Compliance Simplification Act IRA implementation, patient engagement, alternative payment models
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Accelerating Kids’ Access to Care Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act (AKAC) S. 3234, Chronic Disease Flexible Coverage Act
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Protecting Health Care for All Patients Act of 2023
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.485 - Protecting Health Care for All Patients Act of 2023 IRA implementation, patient engagement, alternative payment models
Protecting Health Care for All Patients Act of 2023
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.485 - Protecting Health Care for All Patients Act of 2023 IRA implementation, patient engagement, alternative payment models
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency
Lower Costs, More Transparency Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
Implementation of the special diabetes program, renewal of the special diabetes program, artificial pancreas program, NIH, innovation in drug development for diabetes, insulin access and affordability H.R. 5378 Lower Costs, More Transparency Act S. 1269 - INSULIN Act of 2023 S. 1855 Special Diabetes Program Reauthorization Act of 2023
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation, FY25 appropriations
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars, 340B
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act Prescription drug access and affordability, pricing, transparency, biosimilars, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
Further Continuing Appropriations and Other Extensions Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
Federal budget issues H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024
MAPS Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
MAPS Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Medicare & Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FLAGSHIP PIONEERING via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Preemptive/preventive health, pandemic preparedness, life science innovation and competitiveness, biomanufacturing, AI policy and regulation, rare disease policy and regulation, platform technology policy and regulation, broad based investment in US biotech
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
VERTEX PHARMACEUTICALS INCORPORATED via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Federal budget issues
Alternatives to PAIN Act, IRA, innovation, health disparities, orphan drugs, 340B, opioid alternative medicines, SUPPORT Act reauthorization, awareness of rare kidney disorders
Medicare & Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
IRA, medication affordability and access, general diabetes prevention, obesity, impacts of drug shortages
Treat and Reduce Obesity Act, obesity treatment
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHRMA via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Federal budget issues
Medicare & Medicaid payment and coverage issues, transparency, drug pricing in federal programs
IRA, supply chain integrity, innovation, drug pricing in federal programs, transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL MYERS SQUIBB via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
IRA, Medicare & Medicaid payment and coverage issues
prescription drug access and affordability, pricing, transparency, drug pricing in federal programs
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SAS via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
program integrity and technology reform
IRA, medical review pilot, data use by Medicare Administrative Contractors, program integrity and technology reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
SAREPTA THERAPEUTICS via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
innovation, Duchenne Muscular Dystrophy, platform technologies, value based contracting, gene therapy
Medicaid drug rebate program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid value based payment rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Federal budget issues
organ donation, procurement and transplant issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Federal budget issues
IRA, innovation, drug pricing in federal programs, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars, PAHPA
IRA, Medicare and Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN INVESTMENT COUNCIL via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Legislation affecting the regulation of private equity and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CRINETICS PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
innovation, prescription drug pricing
Medicare policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASTELLAS PHARMA US, INC via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
menopause, drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Federal budget issues
MINI Act, IRA, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies, EPIC Act, supply chain, drug pricing and drug discount programs in federal programs, international drug reference pricing
bio pharmaceutical reimbursement issues, IRA
ABBVIE INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
drug pricing in federal programs, transparency, prescription drug pricing and access, beneficiary access, IRA
Part B, Part D, drug pricing and access, negotiation,
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GENENTECH, INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
MINI Act, IRA, Medicare & Medicaid payment and coverage issues, CMMI, orphan drugs
IRA, drug pricing and access, transparency, drug pricing in federal programs, PAPH reauthorization, supply chain
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JAZZ PHARMACEUTICALS INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Regulation of botanical products Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing Expiring healthcare extenders Issues related to BIOSECURE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026
S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
QUEST DIAGNOSTICS via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
diagnostics, clinical lab reimbursement issues, savings access to lab service, supply chain
physician fee schedule, savings access to lab services
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
IRA, transparency, vaccines, coverage and access
IRA, supply chain integrity, drug pricing in federal programs, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOUNDATION MEDICINE via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
LDT, companion diagnostics, testing, innovation, lab transparency, PAPHA reauthorization, early detection screening
companion diagnostics, payment issues
supply chain
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Federal budget issues
Access and affordability, telehealth coverage, social determinates of health, health savings accounts
Medicare & Medicaid reimbursement and coverage issues, Medicare Advantage
ELI LILLY AND COMPANY via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
IRA, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, drug pricing in federal programs
Medicare & Medicaid payment and coverage issues, Medicare Part D, Medicare Part B, drug pricing in federal programs
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
Medicare & Medicaid coverage and payment issues, regulatory and payment issues, IRA
IRA, prescription drug pricing, prescription drug access and affordability, transparency, drug pricing in federal programs
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Federal budget issues
Medicare & Medicaid payment and coverage issues
IRA, innovation, drug pricing in federal programs, orphan drugs, PAPHA reauthorization, competitiveness, supply chain, vaccine access and coverage
ASTRAZENECA via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
Medicare and Medicaid drug and coverage issues, orphan drugs
IRA, drug pricing in federal programs, orphan drug issues, oncology, transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT (FORMERLY KNOWN AS ALERE INC.) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
infant formula, diagnostics, regulation, supply chain, changes to the organ national transplant program, LDTs, Future Pharmacy, physician fee schedule reform
Medicare reimbursement, Medicare competitive bidding for diabetics supplies, diagnostics, self-testing, nutrition, emerging medical device technology, national coverage decisions
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
IRA, SCREENS for Cancer Act, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
federal budget issues
Medicare & Medicaid policy and reimbursement issues, MCED
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMNEAL PHARMACEUTICALS, INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
drug shortages, critical medicines limited to antibiotics and antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE AMPUTEE COALITION via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
veterans, disability policy
federal budget issues
education and awareness on issues of relevance to individuals with limb loss and limb difference
AMYLYX PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
rare disease and access to innovation
rare disease and access to innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BD (BECTON, DICKINSON AND COMPANY) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
IRA, diagnostics, supply chain, privacy
Medicare coverage and reimbursement, diagnostics
CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
General issues related to drug shortages, supply chain
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EXCELLUS HEALTH PLAN, INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Medicare Advantage, Medicare reimbursement and payment issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
hospice reimbursement and policy issues
hospice care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH CARE SERVICE CORPORATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Access and affordability
Medicare & Medicaid payment and coverage issues, Medicare Advantage
Issues related to tax advantage savings vehicles for health expenses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VALNEVA USA, INC via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Strengthening America's Strategic National Stockpile Act, State Strategic Stockpile Act, vaccine access, pandemic preparedness, PAHPA reauthorization
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACCENTURE FEDERAL SERVICES via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
changes to the organ national transplant program
operational and contract issues
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAZON.COM SERVICES LLC via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
primary care issues, high-deductible health plan, telehealth coverage policies, tele-prescribing, direct to consumer, price transparency, AI policy
CMMI direct contracting program, health savings account, Medicare Advantage, Medicare Part D policy, AI policy, value-based care
issues related to tax advantage saving vehicles for health expenses
AMERICAN OSTEOPATHIC ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
health care access and affordability, workforce reauthorization, Medicare physician payment reform, physician workforce
Medicare physician payment, graduate medical education, MedPAC, resident physician shortage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS BLUE SHIELD ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
Medicare & Medicaid payment and coverage issues, Medicare Advantage
telehealth, coverage, health savings accounts, transparency
OPTION CARE HEALTH via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Federal budget issues
Preserving Patient Access to Home Infusion Act, Medicare coverage and payment for home infusion services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
IDORSIA PHARMACEUTICALS US INC via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
policies related to the regulation of and access to insomnia treatments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADVAMED via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
imaging policy, device regulation, innovation, coverage decisions, AI, device shortages, device servicing and manufacturing
Medicare coverage regulation and reimbursement of imaging services, Medicare physician payment, equipment maintenance, coding, HOPPS, E&M codes/budget neutrality, AI coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALZHEIMER'S ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
federal budget issues
care planning, home and community based care, innovation, NAPA, BOLD Act, Advancing America's Interests Act, ADAPT Act, ASAP Act
Medicare & Medicaid coverage and reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · 3A
Opioid Abuse - General issues related to access to medication assisted treatment General Issues Related to report language regarding paper inserts
General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain Proposed Physician Fee Schedule Rule
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ADULT VACCINE ACCESS COALITION via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Vaccine access
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUEPRINT BIOSECURITY ACTION via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
health care preparedness
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
IRA, drug pricing in federal programs, biosimilars, orphan drugs, prescription drug access & reimbursement, FDA issues, transparency
Medicare coverage and reimbursement issues, Medicare Part B reimbursement, transparency, prescription drug pricing and access, drug pricing in federal programs
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Opioid Abuse - General issues related to access to medication assisted treatment General Issues Related to report language regarding paper inserts
General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
HANSA BIOPHARMA via TARPLIN, DOWNS & YOUNG, LLC
2025 · third_quarter · Q3
Kidney issues, access to innovation, rare disease issues, organ rejection
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
BOEHRINGER INGELHEIM via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
Medicare & Medicaid coverage and payment issues, regulatory and payment issues, IRA
IRA, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HANSA BIOPHARMA via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Kidney issues, access to innovation, rare disease issues, organ rejection
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
ASTELLAS PHARMA US, INC via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
menopause, drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Federal budget issues
organ donation, procurement and transplant issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Drug safety, prescription drug abuse, value of prescription drugs; HR 946/S 1862 Orphan Cures Act; Health care issues H.R. 1 (Public Law No: 119-21)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
innovation, Duchenne Muscular Dystrophy, platform technologies, value based contracting, gene therapy
Medicaid drug rebate program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid value based payment rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Federal budget issues
Alternatives to PAIN Act, IRA, innovation, health disparities, orphan drugs, 340B, opioid alternative medicines, SUPPORT Act reauthorization, awareness of rare kidney disorders
Medicare & Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADULT VACCINE ACCESS COALITION via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Vaccine access
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Federal budget issues
Medicare & Medicaid payment and coverage issues, transparency, 340B
IRA, supply chain integrity, innovation, 340B, transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
IRA, medication affordability and access, general diabetes prevention, obesity
Treat and Reduce Obesity Act, obesity treatment
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
General Issues Related to Last In, First Out Accounting method
Federal budget issues
Opioid Abuse - General issues related to access to medication assisted treatment
GENENTECH, INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
MINI Act, IRA, Medicare & Medicaid payment and coverage issues, CMMI, orphan drugs
IRA, drug pricing and access, transparency, 340B, PAPH reauthorization, supply chain
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES, INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
IRA, pharmaceuticals access and affordability, 340B, HCV screening, drug pricing and access, HIV, oncology, PAHPA reauthorization
Medicare & Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Federal budget issues
IRA, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars, PAHPA
IRA, Medicare and Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CRINETICS PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
innovation, prescription drug pricing
Medicare policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Federal budget issues
MINI Act, IRA, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies, EPIC Act, supply chain
bio pharmaceutical reimbursement issues, IRA
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL MYERS SQUIBB via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
IRA, Medicare & Medicaid payment and coverage issues
prescription drug access and affordability, pricing, transparency, 340B
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
BLUEPRINT BIOSECURITY ACTION via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
health care preparedness
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN INVESTMENT COUNCIL via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Legislation affecting the regulation of private equity and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FLAGSHIP PIONEERING via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Preemptive/preventive health, pandemic preparedness, life science innovation and competitiveness, biomanufacturing, AI policy and regulation, rare disease policy and regulation, platform technology policy and regulation, ag-biotech policy and regulation
federal budget issues
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ABBVIE INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
340B, transparency, prescription drug pricing and access, beneficiary access, IRA
Part B, Part D, drug pricing and access, negotiation
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAS via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
program integrity and technology reform
IRA, medical review pilot, data use by Medicare Administrative Contractors, program integrity and technology reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
VALNEVA USA, INC via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Strengthening America's Strategic National Stockpile Act, State Strategic Stockpile Act, vaccine access, pandemic preparedness, PAHPA reauthorization
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
IRA, transparency, vaccines, coverage and access
IRA, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
QUEST DIAGNOSTICS via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
diagnostics, clinical lab reimbursement issues, savings access to lab service
physician fee schedule, savings access to lab services
federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTION CARE HEALTH via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Federal budget issues
Preserving Patient Access to Home Infusion Act, Medicare coverage and payment for home infusion services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
IRA, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
Medicare & Medicaid payment and coverage issues, Medicare Part D, Medicare Part B, 340B
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH CARE SERVICE CORPORATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Access and affordability
Medicare & Medicaid payment and coverage issues, Medicare Advantage
Issues related to tax advantage savings vehicles for health expenses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
hospice reimbursement and policy issues
hospice care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXCELLUS HEALTH PLAN, INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Medicare Advantage, Medicare reimbursement and payment issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Federal budget issues
Access and affordability, hospital payment policy, telehealth coverage, social determinates of health, health savings accounts
Medicare & Medicaid reimbursement and coverage issues, Medicare Advantage
BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
SCREEN for Type 1 Diabetes Act, INSULIN Act, AKAC Act, Chronic Disease Flexible Coverage Act, Special Diabetes Program
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Federal budget issues
Medicare & Medicaid payment and coverage issues
IRA, innovation, 340B, orphan drugs, PAPHA reauthorization, competitiveness, supply chain, vaccine access and coverage
BD (BECTON, DICKINSON AND COMPANY) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
IRA, diagnostics, supply chain, privacy
Medicare coverage and reimbursement, diagnostics
BLUE CROSS BLUE SHIELD ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
Medicare & Medicaid payment and coverage issues, Medicare Advantage
telehealth, coverage, health savings accounts, transparency
ASTRAZENECA via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
Medicare and Medicaid drug and coverage issues, orphan drugs
IRA, 340B, orphan drug issues, oncology, transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN OSTEOPATHIC ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
health care access and affordability, workforce reauthorization, Medicare physician payment reform, physician workforce
Medicare physician payment, graduate medical education, MedPAC, resident physician shortage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE AMPUTEE COALITION via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
veterans, disability policy
federal budget issues
education and awareness on issues of relevance to individuals with limb loss and limb difference
AMNEAL PHARMACEUTICALS, INC. via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
drug shortages, critical medicines limited to antibiotics and antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
IRA, 340B, biosimilars, orphan drugs, prescription drug access & reimbursement, FDA issues, transparency
Medicare coverage and reimbursement issues, Medicare Part B reimbursement, transparency, prescription drug pricing and access, 340B
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMAZON.COM SERVICES LLC via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
primary care issues, high-deductible health plan, telehealth coverage policies, tele-prescribing, direct to consumer, price transparency
CMMI direct contracting program, health savings account, Medicare Advantage, Medicare Part D policy
issues related to tax advantage saving vehicles for health expenses
ALZHEIMER'S ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
federal budget issues
care planning, home and community based care, innovation, NAPA, BOLD Act, Advancing America's Interests Act, ADAPT Act, ASAP Act
Medicare & Medicaid coverage and reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
IRA, SCREENS for Cancer Act, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
federal budget issues
Medicare & Medicaid policy and reimbursement issues, MCED
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT (FORMERLY KNOWN AS ALERE INC.) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
Medicare reimbursement, Medicare competitive bidding for diabetics supplies, diagnostics, self-testing, nutrition, emerging medical device technology, national coverage decisions
issues related to national trade
federal budget issues
IDORSIA PHARMACEUTICALS US INC via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
policies related to the regulation of and access to insomnia treatments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION MEDICINE via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
LDT, companion diagnostics, testing, innovation, lab transparency, PAPHA reauthorization, early detection screening
companion diagnostics, payment issues
supply chain
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMYLYX PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
rare disease and access to innovation
rare disease and access to innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
imaging policy, device regulation, innovation, coverage decisions, AI, device shortages, device servicing and manufacturing
Medicare coverage regulation and reimbursement of imaging services, Medicare physician payment, equipment maintenance, coding, HOPPS, E&M codes/budget neutrality, AI coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) via TARPLIN, DOWNS & YOUNG, LLC
2025 · second_quarter · Q2
General issues related to drug shortages, supply chain
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
tariffs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
health care access and quality issues
Issues related to tax advantage savings vehicles for health expenses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
vaccine policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
issues related to national trade
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
education and awareness on issues of relevance to individuals with limb loss and limb difference
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
product shortages related to EPA regulation
supply chain, US competitiveness
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
issues related to tax advantage savings vehicles for health expenses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
General Issues Related to Drug Shortages and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
health care access and quality issues
Issues related to tax advantage savings vehicles for health expenses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
vaccine policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
product shortages related to EPA regulation
supply chain, US competitiveness
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
issues related to tax advantage savings vehicles for health expenses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
education and awareness on issues of relevance to individuals with limb loss and limb difference
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
infant formula, diagnostics, regulation, supply chain, changes to the organ national transplant program, LDTs, Future Pharmacy, physician fee schedule reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office